#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian epithelial cancer Chronic granulomatous disease Acromegaly Gaucher's disease type I Hyperphagia Stevens-Johnson syndrome Cryoglobulinaemia Leukodystrophy Immunodeficiency common variable Glomerulonephritis Heritable pulmonary arterial hypertension Mucopolysaccharidosis II Measles Fibrous dysplasia of bone Arrhythmogenic right ventricular dysplasia More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Trials in Disease Mantle cell lymphoma stage II – Diagnostics Pemphigus – Life with Disease Uterine leiomyosarcoma – Basic Information Sarcoidosis – Diagnostics Methylmalonic acidaemia Carcinoid syndrome – Diagnostics Familial haemophagocytic lymphohistiocytosis Testicular leiomyosarcoma – Basic Information Pulmonary fibrosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rintatolimod Vatiquinone Olmesartan Medoxomil Osimertinib Salmeterol Xinafoate MEGESTROL ACETATE Regn7075 Cibotercept Fampridine AZD6234 Abc-15A-116 Dapagliflozin Trospium Chloride S227928 Propylene Glycol Captopril Hydrochlorothiazide Degarelix Vosoritide Itepekimab More therapies…

    Learn about Your Condition

    Lymphangioma Vasospasm Infection Head injury Papilloma viral infection VEXAS syndrome Lymphoma Muscle strain Mantle cell lymphoma stage II Splenic marginal zone lymphoma Pulmonary congestion Urticaria chronic Bronchiectasis Mastocytosis Gastrectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • A Study of Prednisolone Compared to Placebo for Patients with Vestibular Neuritis to Evaluate Effects on Balance and Dizziness Symptoms

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Vestibular disorder
    Investigated Drugs:
    • Prednisolone
    Denmark Norway Sweden

  • A study testing hydroxychloroquine to reduce brain inflammation in patients with progressive multiple sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    • Multiple sclerosis
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    Finland

  • Testing UCPVax vaccine with or without pembrolizumab and temozolomide in patients with unmethylated MGMT glioblastoma after initial treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Ucp4
    • Temozolomide
    • Pembrolizumab
    France

  • Testing Antibiotic Treatment Strategies for Patients with Bladder Bacteria Without Symptoms Receiving Botulinum Toxin A Bladder Injections

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Aztreonam
    • Cefixime
    • Fosfomycin Trometamol
    France

  • A Study of Candesartan to Prevent Chronic Cluster Headache Attacks in Adults with Chronic Cluster Headache

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Candesartan
    Denmark Norway

  • A Study of Candesartan Compared to Placebo in Adults with Episodic Cluster Headache to Prevent Severe Headache Attacks

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Candesartan
    Denmark Norway
Previous Page
1 … 67 68 69 70 71 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!